| Barchart Demo Center |
$2.69
-0.13 (-4.61%)
as of Dec 5, 2019
as of Dec 5, 2019
| Last | 2.69 |
|---|---|
| Change | -0.13 (-4.61%) |
| Open | 2.82 |
| Prev. Close | 2.82 |
| Today's Range |
2.63
2.84
|
| 52wk Range |
2.06
11.29
|
| Volume | 2,210,360 |
| Avg Volume | 3,506,498 |
Perfomance Comparison
| Name | Today | 3-Month | 1-Year |
|---|---|---|---|
| HEXO.TO |
 -4.61% |
 -50.91% |
-47.56% |
| $TXCX |
-0.25% |
 +0.42% |
 +11.01% |
| $TXCI |
-0.41% |
+0.13% |
+9.67% |
| DJIA |
+0.10% |
+2.62% |
+10.59% |
| S&P 500 |
+0.15% |
+4.44% |
+15.46% |
Key Statistics
| Annual EPS | -0.38 |
|---|---|
| Dividend Yield | N/A |
| P/E Ratio | N/A |
| Market Capitalization, $K | 724,792 |
| Weighted Alpha | -47.90 |
| Standard Deviation | -0.49 |
| Profit Margin | -1.72% |
| Beta | 5.01 |
Growth Rates
| YTD | -42.89% | |||
| 1-Year | -45.77% | |||
| 3-Year | +317.78% |
Opinion
| Sell | Hold | Buy |
Recent Headlines
US FDA Breakthrough Therapy Designation for Mushrooms
PR Newswire via COMTEX - 10:30AM EST
For the second year, the U.S. FDA designated psilocybin, a compound found in hallucinogenic mushrooms, as a "breakthrough therapy" for the treatment of major depressive disorder (MDD). "This designation, which is designed to exped(full story)
BOSQF: 0.1820 (-0.0046), HEXO: 2.06 (-0.07), HEXO.TO: 2.69 (-0.13), TCNNF: 13.3041 (+0.2141), TGOD.TO: 0.85 (+0.02)
U.S. Support for Cannabis Legalization Just Increased
PR Newswire via COMTEX - Mon Dec 02, 09:00AM EST
Many more Americans now support cannabis legalization. A Pew Research Center survey now finds that 67% are in support. That's up from 62% year. Better, the House Judiciary Committee just passed The Marijuana Opportunity Reinvestme(full story)
SPLIF: 0.0561 (-0.0001), APHA: 4.68 (+0.01), APHA.TO: 6.16 (-0.02), TLRY: 18.39 (-0.37), HEXO: 2.06 (-0.07)
Most actively traded companies on the TSX
CP - Thu Nov 28, 04:27PM EST
TORONTO — Some of the most active companies traded Thursday on the Toronto Stock Exchange:(full story)